Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy

References

• Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol. 2005;56:155–167.
   PubMed Web of Science ®Google Scholar
• Dierickx D, Tousseyn T, Gheysens O. How we diagnose and treat posttransplant lymphoproliferative disorders. Blood. 2015;126:2274–2283.
   PubMed Web of Science ®Google Scholar
• Dierickx D, Tousseyn T, Sagaert X, et al. Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma. 2013;54:2433–2440.
   PubMed Web of Science ®Google Scholar
• Gallego S, Llort A, Gros L, et al. Post-transplant lymphoproliferative disorders in children: the role of chemotherapy in the era of rituximab. Pediatr Transplant. 2010;14:61–66.
   PubMed Web of Science ®Google Scholar
• Scarsbrook AF, Warakaulle DR, Dattani M, et al. Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances. Clin Radiol. 2005;60:47–55.
   PubMed Web of Science ®Google Scholar
• Cho MC, Park CJ, Huh J, et al. Bone marrow findings of 23 Korean post-transplant lymphoproliferative disorder patients: a single-center experience. Clin Transplant. 2012;26:E381–E387.
   PubMed Web of Science ®Google Scholar
• Izadi M, Fazel M, Saadat SH, et al. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int Survey J Cancer Res Ther. 2012;8:62–67.
   PubMed Web of Science ®Google Scholar
• Cheson BD. Role of functional imaging in the management of lymphoma. J Clin Oncol. 2011;29:1844–1854.
   PubMed Web of Science ®Google Scholar
• Kwee TC, Kwee RM, Nievelstein RA. Imaging in staging of malignant lymphoma: a systematic review. Blood. 2008;111:504–516.
   PubMed Web of Science ®Google Scholar
• Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32:3048–3058.
   PubMed Web of Science ®Google Scholar
• Khan AB, Barrington SF, Mikhaeel NG, et al. PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement. Blood. 2013;122:61–67.
   PubMed Web of Science ®Google Scholar
• Berthet L, Cochet A, Kanoun S, et al. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy. J Nucl Med. 2013;54:1244–1250.
   PubMed Web of Science ®Google Scholar
• Adams HJ, Kwee TC, de Keizer B, et al. FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2014;41:565–574.
   PubMed Web of Science ®Google Scholar
• El-Galaly TC, d'Amore F, Mylam KJ, et al. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma. J Clin Oncol. 2012;30:4508–4514.
   PubMed Web of Science ®Google Scholar
• Adams HJ, Kwee TC, de Keizer B, et al. Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Ann Oncol. 2014;25:921–927.
   PubMed Web of Science ®Google Scholar
• Weiler-Sagie M, Kagna O, Dann EJ, et al. Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT. Eur J Nucl Med Mol Imaging. 2014;41:1133–1140.
   PubMed Web of Science ®Google Scholar
• Pakos EE, Fotopoulos AD, Ioannidis JP. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med. 2005;46:958–963.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–3068.
   PubMed Web of Science ®Google Scholar
• Swerdlow A, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008:343–349.
   Google Scholar
• Bianchi E, Pascual M, Nicod M, et al. Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease. Transplantation. 2008;85:707–712.
   PubMed Web of Science ®Google Scholar
• Panagiotidis E, Quigley AM, Pencharz D, et al. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder. Leuk Lymphoma. 2014;55:515–519.
   PubMed Web of Science ®Google Scholar
• Takehana CS, Twist CJ, Mosci C, et al. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder. Nucl Med Commun. 2014;35:276–281.
   PubMed Web of Science ®Google Scholar
• Dierickx D, Tousseyn T, Requile A, et al. The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder. Haematologica. 2013;98:771–775.
   PubMed Web of Science ®Google Scholar
• Elstrom RL, Tsai DE, Vergilio JA, et al. Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. Clin Lymphoma. 2004;5:62–64.
   PubMedGoogle Scholar
• Salaun PY, Gastinne T, Bodet-Milin C, et al. Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation? Eur J Nucl Med Mol Imaging. 2009;36:1813–1821.
   PubMed Web of Science ®Google Scholar